Barclays raised the firm’s price target on Boston Scientific (BSX) to $118 from $111 and keeps an Overweight rating on the shares. The firm updated the company’s projections to get in line with management’s organic growth outlook.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BSX:
- Boston Scientific price target raised to $122 from $119 at Raymond James
- Boston Scientific price target raised to $120 from $110 at Truist
- Boston Scientific price target raised to $115 from $100 at Stifel
- Boston Scientific price target raised to $120 from $112 at Baird
- Boston Scientific price target raised to $117 from $101 at Canaccord